[ Price : $8.95]
Eli Lilly and Merck extend an existing collaboration to evaluate the combination of Lillys Alimta and Mercks Keytruda in a pivotal...[ Price : $8.95]
FDA posts its fifth, sixth and seventh reports on backlogs in postmarketing reports and commitments.[ Price : $8.95]
FDA says that Merck and Pfizers avelumab is a breakthrough therapy for patients with metastatic Merkel cell carcinoma.[ Price : $8.95]
FDA makes presentations biomarkers, the benefit/risk framework, and patient-reported outcomes at a PDUFA 6 reauthorization stakeho...[ Price : $8.95]
CDRH director Jeffrey Shuren says his Center intends to finalize early next year its guidance on aFramework for Regulatory Oversig...[ Price : $8.95]
FDA issues AngioDynamics a close-out letter effectively resolving promotional issues raised in a 2011 Warning Letter involving its...[ Price : $8.95]
Federal Register Notice: FDA publishes a list of approved PMAs and their safety and effectiveness summaries.[ Price : $8.95]
The Washington Legal Foundation calls on the Centers for Disease Control and Prevention (CDC) to withdraw its Draft Guideline for ...